XML 121 R102.htm IDEA: XBRL DOCUMENT
v3.23.1

Related Parties - Restricted Stock Program (Detail) R$ / shares in Units, R$ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2022 BRL (R$) shares R$ / shares
Disclosure of transactions between related parties [line items] |
Number of shares granted (Quantity) | shares | 8,934,704
Total exercisable grant costs, including taxes | R$ 244,295
Accumulated recognized exercisable grant costs | (64,523)
Accumulated unrecognized exercisable grant costs | R$ 179,772
Restricted Stock Award [Member] | Grant Date, April 4, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 4, 2018
Number of shares granted (Quantity) | shares | 6,658
Vesting period | 2023
Market price of shares on the grant date | R$ / shares | R$ 34.35
Total exercisable grant costs, including taxes | R$ 427
Accumulated recognized exercisable grant costs | (406)
Accumulated unrecognized exercisable grant costs | R$ 21
Restricted Stock Award [Member] | Grant Date, September 19, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 19, 2018
Number of shares granted (Quantity) | shares | 80,000
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 19.58
Total exercisable grant costs, including taxes | R$ 2,675
Accumulated recognized exercisable grant costs | (1,895)
Accumulated unrecognized exercisable grant costs | R$ 780
Restricted Stock Award [Member] | Grant Date, September 24, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 24, 2018
Number of shares granted (Quantity) | shares | 80,000
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 18.4
Total exercisable grant costs, including taxes | R$ 2,528
Accumulated recognized exercisable grant costs | (1,791)
Accumulated unrecognized exercisable grant costs | R$ 737
Restricted Stock Award [Member] | Grant Date, April 3, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 3, 2019
Number of shares granted (Quantity) | shares | 74,916
Vesting period | 2023 and 2024
Market price of shares on the grant date | R$ / shares | R$ 23.25
Total exercisable grant costs, including taxes | R$ 3,264
Accumulated recognized exercisable grant costs | (2,758)
Accumulated unrecognized exercisable grant costs | R$ 506
Restricted Stock Award [Member] | Grant Date, September 2, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 2, 2019
Number of shares granted (Quantity) | shares | 320,000
Vesting period | 2025
Market price of shares on the grant date | R$ / shares | R$ 16.42
Total exercisable grant costs, including taxes | R$ 9,013
Accumulated recognized exercisable grant costs | (5,007)
Accumulated unrecognized exercisable grant costs | R$ 4,006
Restricted Stock Award [Member] | Grant Date, April 1, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 1, 2020
Number of shares granted (Quantity) | shares | 182,853
Vesting period | 2023 to 2025
Market price of shares on the grant date | R$ / shares | R$ 12.53
Total exercisable grant costs, including taxes | R$ 4,267
Accumulated recognized exercisable grant costs | (3,064)
Accumulated unrecognized exercisable grant costs | R$ 1,203
Restricted Stock Award [Member] | Grant Date, September 16, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 16, 2020
Number of shares granted (Quantity) | shares | 300,000
Vesting period | 2026
Market price of shares on the grant date | R$ / shares | R$ 23.03
Total exercisable grant costs, including taxes | R$ 11,793
Accumulated recognized exercisable grant costs | (4,586)
Accumulated unrecognized exercisable grant costs | R$ 7,207
Restricted Stock Award [Member] | Grant Date, April 7, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 7, 2021
Number of shares granted (Quantity) | shares | 425,422
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 21
Total exercisable grant costs, including taxes | R$ 16,705
Accumulated recognized exercisable grant costs | (9,744)
Accumulated unrecognized exercisable grant costs | R$ 6,961
Restricted Stock Award [Member] | Grant Date, September 22, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 22, 2021
Number of shares granted (Quantity) | shares | 1,000,000
Vesting period | 2027
Market price of shares on the grant date | R$ / shares | R$ 14.17
Total exercisable grant costs, including taxes | R$ 24,363
Accumulated recognized exercisable grant costs | (5,543)
Accumulated unrecognized exercisable grant costs | R$ 18,820
Restricted Stock Award [Member] | Grant Date, April 6, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 6, 2022
Number of shares granted (Quantity) | shares | 777,065
Vesting period | 2025
Market price of shares on the grant date | R$ / shares | R$ 14.16
Total exercisable grant costs, including taxes | R$ 20,573
Accumulated recognized exercisable grant costs | (5,143)
Accumulated unrecognized exercisable grant costs | R$ 15,430
Restricted Stock Award [Member] | Grant Date, September 21, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 21, 2022
Number of shares granted (Quantity) | shares | 2,640,000
Vesting period | 2032
Market price of shares on the grant date | R$ / shares | R$ 12.98
Total exercisable grant costs, including taxes | R$ 64,048
Accumulated recognized exercisable grant costs | (2,135)
Accumulated unrecognized exercisable grant costs | R$ 61,913
Restricted Stock Award [Member] | Grant Date, December 7, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | December 7, 2022
Number of shares granted (Quantity) | shares | 1,500,000
Vesting period | 2032
Market price of shares on the grant date | R$ / shares | R$ 13.47
Total exercisable grant costs, including taxes | R$ 38,125
Accumulated recognized exercisable grant costs | (318)
Accumulated unrecognized exercisable grant costs | R$ 37,807
Performance Stock Award [Member] | Grant Date, April 3, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 3, 2019
Number of shares granted (Quantity) | shares | 37,458
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 23.25
Total exercisable grant costs, including taxes | R$ 1,619
Accumulated recognized exercisable grant costs | (1,214)
Accumulated unrecognized exercisable grant costs | R$ 405
Performance Stock Award [Member] | Grant Date, April 1, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 1, 2020
Number of shares granted (Quantity) | shares | 276,580
Vesting period | 2023 to 2025
Market price of shares on the grant date | R$ / shares | R$ 12.53
Total exercisable grant costs, including taxes | R$ 6,440
Accumulated recognized exercisable grant costs | (4,854)
Accumulated unrecognized exercisable grant costs | R$ 1,586
Performance Stock Award [Member] | Grant Date, April 7, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 7, 2021
Number of shares granted (Quantity) | shares | 454,520
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 21
Total exercisable grant costs, including taxes | R$ 17,824
Accumulated recognized exercisable grant costs | (10,864)
Accumulated unrecognized exercisable grant costs | R$ 6,960
Performance Stock Award [Member] | Grant Date, April 6, 2022 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 6, 2022
Number of shares granted (Quantity) | shares | 779,232
Vesting period | 2025
Market price of shares on the grant date | R$ / shares | R$ 14.16
Total exercisable grant costs, including taxes | R$ 20,631
Accumulated recognized exercisable grant costs | (5,201)
Accumulated unrecognized exercisable grant costs | R$ 15,430

X
- Definition The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph IG23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DateOfGrantOfSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 51 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_51_a&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard -URIDate 2022-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2022-03-24 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of accumulated recognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedRecognizedExercisableGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of accumulated unrecognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedUnrecognizedExercisableGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_RestrictedStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril42018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember192018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember242018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril32019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember22019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril12020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember162020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril72021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember222021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril62022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember212022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateDecember72022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_PerformanceStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |